Cardiac Magnetic Resonance
9
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Assessment of Left Atrial Size and Function by Cardiac Magnetic Resonance
Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis
Multimodal Imaging Assessment of Chronic Kidney Disease Patients at Different Stages From a Cardio-Renal Interaction Perspective
CMR in Myocardial Infarction with Nonobstructive Coronary Arteries
Extracellular Volume Associated With New-Onset Atrial Fibrillation
Role of Multi-modality Imaging in the Assessment of Chemotherapy Related Cardiac Dysfunction Among Cancer Patients
Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals
Cardiac COVID-19 Health Care Workers
Cardiotoxicity in the Elderly